蔚蓝生物：预计2026年向关联方销售产品1500万元

Core Viewpoint - The company announced the approval of the expected daily related transactions for 2026, which will not require shareholder meeting review [1] Group 1: Company Transactions - In the period from January to November 2025, the company sold products worth 8.0795 million yuan to Beidahuang Baoquanling Agricultural and Animal Husbandry Development Co., Ltd. and its subsidiaries, which is below the expected amount of 15 million yuan due to market conditions [1] - For 2026, the company anticipates sales of enzyme preparations and other products amounting to 15 million yuan, representing 1.23% of the same type of business [1] - The pricing for these transactions will be based on market prices, ensuring that the company's independence is not affected [1]